Hims & Hers Health, Inc. (New York Stock Exchange:HIMS)
| Market Cap | $3.30B-57.9% |
| Revenue (ttm) | $2.87B+29.8% |
| Net Income | -$190.84M-242.6% |
| EPS | -$0.83-252.7% |
| Shares Out | 226.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,064,118 |
| Open | $15.51 |
| Previous Close | $16.02 |
| Day's Range | $14.51 - $15.96 |
| 52-Week Range | $13.74 - $40.99 |
| Beta | 2.50 |
| Analysts | Hold |
| Price Target | $30.00(+105.48%) |
| Earnings Date | Feb 22, 2027 |
About HIMS
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
5 firms rating HIMS in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 22, 2027Earnings report
$HIMS stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of HIMS by members of U.S. Congress
| Lisa C. McClainHouse / R | Purchase$1.00K – $15.00K | Aug 4, 2025 |
Recently reported changes in HIMS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HIMS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HIMS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
HIMS Revenue by Segment or Geography
| Single Reporting Segment | $890.37M | 76.38% |
| Customer acquisition costs | $214.14M | 18.37% |
| Operations and support | $36.31M | 3.12% |
| Technology and development | $14.64M | 1.26% |
| Marketing | $10.18M | 0.87% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New HIMS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HIMS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in HIMS
| VTIVanguard Morningstar Total Stock Market ETF | $147.46M |
| VBVanguard Morningstar Small-Cap ETF | $132.63M |
| IJHiShares Core S&P Mid-Cap ETF | $122.06M |
| IWMiShares Russell 2000 ETF | $90.46M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $74.23M |
| VXFVanguard Extended Market ETF | $66.38M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from HIMS’s recent data — informational, not investment advice
What’s Behind the Score
News check: Mixed coverage: Product launches (Peptides+, obesity drugs) and positive regulatory developments offset by earnings misses, stock declines, and valuation concerns.
Recent Insider Activity
Insider Score Trend Over Time
-35.0 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| EDOC | Global X Telemedicine & Digital Health ETF | 5.74% |
| GLAM | Corgi ETF Trust I - Corgi Beauty, Skincare & Aesthetics ETF | 2.74% |
| HEAL | Global X HealthTech ETF | 2.62% |
| FDHT | FIDELITY DIGITAL HEALTH ETF | 2.60% |
| IBUY | Amplify Online Retail ETF | 2.03% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 1.42% |
| XHS | State Street SPDR S&P Health Care Services ETF | 1.15% |
| RFG | Invesco S&P MidCap 400 Pure Growth ETF | 0.79% |
| YUNG | Corgi ETF Trust I - Longevity Consumer ETF | 0.67% |
| BUZZ | VanEck Social Sentiment ETF | 0.60% |
| QSML | WisdomTree U.S. SmallCap Quality Growth Fund | 0.51% |
| IHF | iShares U.S. Healthcare Providers ETF | 0.51% |
Weight is the stock’s share of each fund’s holdings.
